EVMS receives more than $1 million in federal funds to develop new ways to reverse type ... ( Researchers at the Eastern Virginia ...)

EVMS receives more than $1 million in federal funds to develop new ways to reverse type 1 diabetes

Date:3/25/2010

Researchers at the Eastern Virginia Medical School Strelitz Diabetes Center have been awarded a $1,076,250 grant by the Department of Defense (DoD) Peer Reviewed Medical Research Program to develop new ways of reversing the underlying causes of Type 1 diabetes.

David Taylor-Fishwick, PhD, associate professor of internal medicine and director of the Cell, Molecular and Islet Biology Laboratory, leads the team whose research applies to both regenerative and autoimmune medicine.

"Type 1 diabetes is caused by an autoimmune attack that destroys the insulin-producing beta cells, and the body does not automatically regenerate or replace these cells," explains Dr. Taylor-Fishwick. "The unique challenge in reversing Type 1 diabetes is to regenerate the insulin-producing beta cells and to stop the body's autoimmune attack."

Insulin is the hormone that helps the body convert glucose from food into energy. When the beta cells are destroyed, no insulin can be produced. Insulin replacement therapy helps the body maintain normal glucose levels, but doesn't prevent the serious diabetes health problems such as blindness, nerve damage, heart disease and kidney failure.

Dr. Taylor-Fishwick's research on beta cell regeneration has focused on INGAP (Islet Neogenesis Associated Protein), branded as Exsulin, the breakthrough discovery made by Aaron I. Vinik, PhD, MD, director of research at the Strelitz Diabetes Center, and Dr. Lawrence Rosenberg of McGill University. Published trials of Exsulin demonstrated promising results in both Type 1 and Type 2 diabetes patients.

The DoD grant will fund the next phase in the team's research finding a way to neutralize the immune system's attack of the beta cells. This immune attack occurs at the onset of diabetes and may continue after Type 1 diabetes has appeared. The benefits of this research may also apply to other autoimmune diseases such as lupus and rheumatoid arthritis.

Dr
'/>"/>

Contact: Jina Gaines
gainesjn@evms.edu
757-446-7070
Eastern Virginia Medical School
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. US Wellness, Inc. Receives National Recognition for Laboratory Excellence
2. American Public Health Champion Receives 2010 Stockholm Water Prize
3. Society for New Communications Research Receives Grant to Help Raise Awareness and Reduce Racial and Ethnic Health Disparities
4. BUSM researcher receives prestigious young investigator award
5. Yondelis(R) Receives Five New Approvals Outside the European Economic Area
6. Christiana Care Health Systems Darcy Burbage Receives Oncology Nursing Society Award
7. Moleac Receives BioSpectrum Asia Emerging Company of the Year 2010 Award
8. CoreObjects Receives Project Management Institutes Excellence Award for Diabetes Contribution
9. Zimmer Receives Recognition for Health Economics Data Presented at 77th Annual American Academy of Orthopaedic Surgeons Meeting
10. U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award
11. Intellimed's Popular Data Reporting Software IM-IC (Intelligent Client) Receives Latest Update

Post Your Comments:

Related Image:

EVMS receives more than $1 million in federal funds to develop new ways to reverse type 1 diabetes

(Date:5/22/2013)... Margate City, NJ (PRWEB) May 22, 2013 ... from solved. In some states, up to twenty-seven percent ... half of all bankruptcies of private citizens in the U.S. ... medical care also affects prescription drugs, meaning that many patients ... doctor, or even get them filled at all. That's ...

(Date:5/22/2013)... Beginning Aug. 22, teens are invited ... Spirit of Innovation Challenge . The annual program ... and open to students ages 13 - 18 from ... Challenge celebrates the life and entrepreneurial spirit of astronaut ... The program challenges teens to work in teams of ...

(Date:5/22/2013)... May 22, 2013 The 2013 release of ... is the largest change to hit the field of mental ... is will help prepare for the release with a Webinar ... been trained knowing no other diagnostic scheme besides the now ... manual will be released worldwide. In honor of this event, ...

(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...

(Date:5/22/2013)... May 22 2013 - Research presented today shows ... in rats similar to those produced by drugs ... presented by addiction expert Francesco Leri, Associate Professor ... University of Guelph, suggest food addiction could explain, ... These results were presented at the 2013 ...

Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2 Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2 Health News:What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 2 Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2 Health News:Addiction to unhealthy foods could help explain the global obesity epidemic 2

[0] Lyrica Discount Cards Now Available From MedicationDiscountCard.com [0] Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date [0] What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 [0] Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative [0] Addiction to unhealthy foods could help explain the global obesity epidemic

... the standard treatment regimen for hepatitis C significantly increases the ... to a research report published Monday in the online edition ... team, led by Paul Kwo, M.D., of Indiana University School ... treatment,s effectiveness when given for 48 weeks in one treatment ...

... by researchers at the Bradley Hasbro Children,s Research Center ... some of the well-documented ethnic disparities in pediatric asthma. ... children in the study tended to think they were ... tests actually revealed normal lung function. According to ...

... Adding a direct acting anti-viral drug to the standard ... in the most difficult to treat patients, according to a ... journal The Lancet . The research team, led ... reported that adding the drug nearly doubled the treatment,s effectiveness ...

... The University of Colorado College of Nursing has been ... Health and Human Services, Health Resources and Services Administration ... to provide leadership for high quality healthcare in rural ... a competitively awarded grant to i-LEAD, Innovation in Leadership ...

... Reporter , FRIDAY, Aug. 6 (HealthDay News) -- "Locally grown" ... It,s a concept that has made many Americans scan their ... been raised nearby. But are locally grown foods necessarily ... grown locally will be much healthier; others, not so much. ...

... 2010 SIRIUS XM Radio (NASDAQ: SIRI) today announced ... Doctor Radio Reports: Understanding Autism - Looking for Answers, ... Perri Peltz on which a panel of world-class doctors, ... the latest research and treatment options for autism and ...

Cached Medicine News:Health News:New antiviral drug shows promise for dramatic improvement in hepatitis C treatment 2 Health News:New antiviral drug shows promise for dramatic improvement in hepatitis C treatment 3 Health News:Latino children with asthma less accurate in determining their lung function 2 Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 2 Health News:New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment 3 Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 2 Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 3 Health News:'Locally Grown' May Mean Healthier, But Not Always 2 Health News:'Locally Grown' May Mean Healthier, But Not Always 3 Health News:Sirius XM to broadcast 'Doctor Radio Reports: Understanding Autism -- Looking for Answers' 2

New antiviral drug shows promise for dramatic improvement in hepatitis C treatment Latino children with asthma less accurate in determining their lung function New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment College of Nursing awarded grant for nursing leadership in rural and underserved areas 'Locally Grown' May Mean Healthier, But Not Always Sirius XM to broadcast 'Doctor Radio Reports: Understanding Autism -- Looking for Answers'

(Date:5/22/2013)... 22, 2013 Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options. ...

(Date:5/22/2013)... 22, 2013 Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... of the company at the following conferences. , ... date: Wednesday May 29, 2013 , Presentation time: 12:00 ... Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of these ...

(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...

Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3 Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4 Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2 Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3

[0] Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures [0] Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences [0] Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

... NEW YORK, Nov. 8, 2010 Reportlinker.com ... is available in its catalogue: ... Technology platforms, key players, and early pipeline ... Therapeutic vaccines promise a ...

... Nov. 8, 2010 Reportlinker.com announces that ... in its catalogue: Opportunities ... growth in key regions and therapeutic areas ... The flurry of recent industry acquisitions ...

Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas

... The Summit SI Spinal Fixation ... for rigid posterior fixation of ... spine. The simplicity and versatility ... optimize the construct based on ...

OctaFix is designed specifically to provide stability and fixation where it is most needed....

...

Medicine Products:

Summit SI Spinal Fixation System Octafix Adson Cranial Rongeur Bateman Rongeur